Dmitriy Genkin

Dr. Dmitriy D.
Genkin, MD, is an Executive Chairman at Pharmsynthez PJSC, a Managing Director at FDS Pharma LLP and a Director & Partner at FDS Pharma Associates Ltd. He is on the Board of Directors at Kevelt AS, SynBio LLC, EPhaG AS, CLS Therapeutics, Inc., Peri-Ness Technologies Ltd., Santersus AG, FDS Pharma Associates Ltd. and Xenetic Biosciences, Inc. Dr. Genkin was previously employed as a Non-Executive Director by Xenetic Biosciences, Inc., a Non-Executive Director by Human Stem Cells Institute OJSC, a Non-Executive Director by Xenetic Biosciences, Inc., and a Professor by University College London.
He also served on the board at Xenetic Biosciences Plc.
He received his undergraduate degree from Mechnikov St Petersburg State Medical Academy and a graduate degree from The School of Pharmacy University of London.